(Q33990855)

English

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Steven I. Sherman

object named as

Steven I Sherman

3

0 references

Young Kee Shong

object named as

Young Kee Shong

4

0 references

author name string

Marcia S Brose

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Christopher M Nutting

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Johannes W A Smit

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gerhard Reike

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

John Chung

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Joachim Kalmus

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Christian Kappeler

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Martin Schlumberger

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

11 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

349

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-349

0 references

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Phase II trial of sorafenib in metastatic thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

International patterns and trends in thyroid cancer incidence, 1973-2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Phase II trial of sorafenib in advanced thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3164634

5 July 2018

Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-349

21 January 2018

Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-349

21 January 2018

Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-349

21 January 2018

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-349

21 January 2018

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/21834960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-349

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33990855&oldid=1643728727"